James Courmarcel
Director, Regulatory Affairs at BeiGene | Brussels Metropolitan Area, Belgium
James Courmarcel’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
ContactOut Insights • AI Generated
James Courmarcel serves as the Director of Regulatory Affairs at the pharmaceutical company BeiGene, operating out of the Brussels Metropolitan Area to support oncology drug development. He completed his studies at the Universitat Autònoma de Barcelona and currently advises the business during its transition toward the BeOne Medicines Ltd. rebrand and Swiss redomiciliation. His professional focus aligns with the company’s March 2025 subsidiary restructuring aimed at expanding global patient access to targeted cancer therapies.
BEST APPROACH TO REACH James Courmarcel
Send a personalized LinkedIn message highlighting relevant experience in European pharmaceutical regulatory standards and requesting a brief introductory conversation about supporting BeiGene’s compliance priorities.
Dossier Specialist - Global Documentation and Dossier Management at Bristol-Myers Squibb in July 2026 - July 2026
Director, Regulatory Affairs at BeiGene in February 2024 - Present
Associate Director, European Regulatory Procedure Management at Bristol Myers Squibb in October 2014 - December 2023
Manager European Regulatory Coordination at Bristol Myers Squibb in January 2011 - September 2014
Sr European Regulatory Coordinator at Bristol-Myers Squibb in June 2008 - December 2010
Sr Dossier Specialist - Global Documentation and Dossier Management at Bristol-Myers Squibb in July 2026 - June 2008
Universitat Autònoma de Barcelona, Post-Doc, July 2026
Université catholique de Louvain, Doctor of Philosophy - PhD, July 2026
Université catholique de Louvain, PhD, July 2026
Effective March 17, 2025, The U.S. subsidiary of BeiGene, Ltd. has changed its name to BeOne Medicines USA, Inc. This change comes ahead of our anticipated global rebranding to BeOne Medicines Ltd. and redomiciliation to Switzerland, pending shareholder approval. The new name reflects our commitment to develop innovative medicines and partner with the global community to help as many patients with cancer as possible. To learn more about BeOne Medicines, please follow our new LinkedIn profile @BeOne Medicines.
Discover more about BeiGene
Biotech & Healthcare- Marketing Director and Innovative Solutions- Spain & Portugal
Marketing Director and Innovative Solutions, Spain & Portugal at BeiGene
(February 2022 – Present)
BeiGene - Senior Marketing Director
Senior Marketing Director at BeiGene
(July 2018 – Present)
Field Market Access Senior Manager
Gerente de cuentas a cobrar at Merck Serono
(May 2026 – May 2026)
Enthusiastic leader motivated to go the extra mile to be able to deliver results & wellbeing.
Associate Director, Field Innovation & Capabilities Lead ( Sub-Region Europe) at BeiGene
(November 2023 – Present)
Brand Lead · Product Manager · Marketing · FP&A · Finance Business Partner · Pharma · Biotech · Executive MBA @IE Business School
Associate Director Marketing, Hematology and Solid Tumors at BeiGene
(June 2024 – Present)
Clinical Study Manager in BeiGene
Lead CRA on behalf of Lilly at IQVIA
(May 2026 – May 2026)
What is James Courmarcel email address?
Email James Courmarcel at [email protected] and [email protected]. This email is the most updated James Courmarcel's email found in 2026.
How to contact James Courmarcel?
To contact James Courmarcel send an email to [email protected] or [email protected]. (updated on March 12, 2026)
What company does James Courmarcel work for?
James Courmarcel works for BeiGene.
What is James Courmarcel's role at BeiGene?
James Courmarcel is Director, Regulatory Affairs
What industry does James Courmarcel work in?
James Courmarcel works in the Pharmaceuticals industry.
